November 27, 2017 LEAD PLAINTIFF DEADLINE ALERT: Monteverde & Associates PC Encourages Investors Who Suffered Significant Los...

NEW YORK, Nov. 9, 2017 /PRNewswire/ -- Notice is hereby given that a class action lawsuit has been filed, on behalf of shareholders of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NasdaqGS: ICPT) on behalf of  purchasers of the Company's securities between May 31, 2016 and September 20, 2017, inclusive (the "Class Period").

The investigation focuses on whether Intercept and certain of its officers and/or directors violated federal securities laws.

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Ocaliva entailed undisclosed safety risks, including death, to patients suffering from PBC; and (ii) as a result of the foregoing, Intercept's public statements were materially false and misleading at all relevant times.

On September 12, 2017, Intercept issued a letter warning physicians against overdosing patients with Ocaliva, advising them that the drug has been tied to liver injuries and death among patients suffering from PBC.

As a result, Intercept's share price fell $24.42, or 24.88%, to close at $73.70 on September 21, 2017.

If you wish to serve as lead plaintiff, you must move the Court no later than November 27, 2017.  Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.  If you wish to discuss this action, or have any questions concerning this notice or your rights or interests, please contact:

Click here for more information: https://monteverdelaw.com/investigations/securities/ It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm committed that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing.  Monteverde & Associates PC lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave, Suite 4405
New York, NY 10118
United States of America
[e-mail]
Tel: [phone]

Attorney Advertising. (C) 2017 Monteverde & Associates PC.  Prior results do not guarantee a similar outcome with respect to any future matter. 

View original content with multimedia:http://www.prnewswire.com/news-releases/november-27-2017-lead-plaintiff-deadline-alert-monteverde--associates-pc-encourages-investors-who-suffered-significant-losses-in-intercept-pharmaceuticals-inc-to-contact-the-firm--icpt-300554253.html

SOURCE Monteverde & Associates PC

Copyright 2017 PR Newswire